How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
58
CARE Quote, Financials, Valuation and Earnings
Last price:
$16.30
Seasonality move
:
-1.65%
Day range:
$16.29 - $16.98
52-week range:
$10.95 - $20.40
Dividend yield:
0%
P/E ratio:
15.40x
P/S ratio:
2.81x
P/B ratio:
0.98x
Volume:
35.9K
Avg. volume:
59.9K
1-year change:
29.11%
Market cap:
$377.5M
Revenue:
$132.4M
EPS (TTM):
$1.06
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $127.9M | $133.7M | $158.9M | $137.7M | $132.4M | |
| Revenue Growth (YoY) | 5.21% | 4.47% | 18.88% | -13.33% | -3.86% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $56.3M | $57.3M | $55.8M | $62.5M | $66.6M | |
| Other Inc / (Exp) | $6.9M | $6.9M | $46K | -$1.5M | $68K | |
| Operating Expenses | -$6M | $57.3M | $55.8M | $62.5M | $66.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$45.1M | $35.7M | $61.7M | $28.7M | $30.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $772K | $4.1M | $11.6M | $5.3M | $6.3M | |
| Net Income to Company | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Basic EPS (Cont. Ops) | -$1.74 | $1.19 | $2.03 | $1.00 | $1.06 | |
| Diluted EPS (Cont. Ops) | -$1.74 | $1.19 | $2.03 | $1.00 | $1.06 | |
| Weighted Average Basic Share | $26.4M | $26.3M | $24.6M | $23.2M | $22.8M | |
| Weighted Average Diluted Share | $26.4M | $26.3M | $24.6M | $23.2M | $22.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$9.3M | $58.4M | $82M | $102.8M | $138.1M | |
| Revenue (Reported) | $127.9M | $133.7M | $158.9M | $137.7M | $132.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$9.3M | $58.4M | $82M | $102.8M | $138.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.6M | $32.9M | $46.7M | $29.9M | $33.5M | |
| Revenue Growth (YoY) | 11.1% | 4.13% | 42.11% | -36.13% | 12.36% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $10.6M | $11.1M | $15.7M | $17.4M | $17.4M | |
| Other Inc / (Exp) | $959K | $419K | -$2K | -$1.5M | $32K | |
| Operating Expenses | $10.5M | $11.2M | $15.7M | $17.4M | $17.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.1M | $7M | $19.1M | -$1.9M | $10.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $138K | $1.4M | $3.5M | -$1K | $2.4M | |
| Net Income to Company | $2.9M | $5.6M | $15.6M | -$1.9M | $8.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.9M | $5.6M | $15.6M | -$1.9M | $8.3M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.21 | $0.65 | -$0.08 | $0.36 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.21 | $0.65 | -$0.08 | $0.36 | |
| Weighted Average Basic Share | $26.4M | $26.4M | $23.9M | $22.7M | $22.8M | |
| Weighted Average Diluted Share | $26.4M | $26.4M | $23.9M | $22.7M | $22.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $10.4M | $11.9M | $25.8M | $22.6M | $38M | |
| Revenue (Reported) | $31.6M | $32.9M | $46.7M | $29.9M | $33.5M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $10.4M | $11.9M | $25.8M | $22.6M | $38M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $127.9M | $133.7M | $158.9M | $137.7M | $132.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $56.3M | $57.3M | $56.3M | $62.9M | $67M | |
| Other Inc / (Exp) | $6.9M | $6.9M | $46K | -$1.5M | $68K | |
| Operating Expenses | -$6M | $57.3M | $57.4M | $62.9M | $67M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$45.1M | $35.7M | $61.7M | $28.7M | $30.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $772K | $4.1M | $11.6M | $5.3M | $6.3M | |
| Net Income to Company | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Basic EPS (Cont. Ops) | -$1.74 | $1.20 | $2.04 | $0.99 | $1.06 | |
| Diluted EPS (Cont. Ops) | -$1.74 | $1.20 | $2.04 | $0.99 | $1.06 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$9.3M | $58.4M | $82M | $102.8M | $138.1M | |
| Revenue (Reported) | $127.9M | $133.7M | $158.9M | $137.7M | $132.4M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$9.3M | $58.4M | $82M | $102.8M | $138.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $133.7M | $158.9M | $137.7M | $132.4M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $57.3M | $56.3M | $62.9M | $67M | -- | |
| Other Inc / (Exp) | $6.9M | $46K | -$1.5M | $68K | -- | |
| Operating Expenses | $57.3M | $57.4M | $62.9M | $67M | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $35.7M | $61.7M | $28.7M | $30.9M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.1M | $11.6M | $5.3M | $6.3M | -- | |
| Net Income to Company | $31.6M | $50.1M | $23.4M | $24.5M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $31.6M | $50.1M | $23.4M | $24.5M | -- | |
| Basic EPS (Cont. Ops) | $1.20 | $2.04 | $0.99 | $1.06 | -- | |
| Diluted EPS (Cont. Ops) | $1.20 | $2.04 | $0.99 | $1.06 | -- | |
| Weighted Average Basic Share | $105.3M | $98.4M | $93M | $91.3M | -- | |
| Weighted Average Diluted Share | $105.3M | $98.4M | $93M | $91.3M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $58.4M | $82M | $102.8M | $138.1M | -- | |
| Revenue (Reported) | $133.7M | $158.9M | $137.7M | $132.4M | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $58.4M | $82M | $102.8M | $138.1M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $241.9M | $277.8M | $46.9M | $54.5M | $131.2M | |
| Short Term Investments | $778.7M | $922.4M | $836.3M | $719.6M | $655M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1B | $1.2B | $883.1M | $833.5M | $849.6M | |
| Property Plant And Equipment | $85.3M | $75.3M | $72.1M | $73.7M | $74.3M | |
| Long-Term Investments | $778.7M | $922.4M | $836.3M | $719.6M | $665M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.2B | $4.1B | $4.2B | $4.5B | $4.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $17.9M | -- | -- | |
| Long-Term Debt | $35M | $7M | $180.6M | $393.4M | $70M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.7B | $3.7B | $3.9B | $4.2B | $4.3B | |
| Common Stock | $26.4M | $26.4M | $24M | $23M | $23.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $440.2M | $407.6M | $328.6M | $351.2M | $384.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $440.2M | $407.6M | $328.6M | $351.2M | $384.3M | |
| Total Liabilities and Equity | $4.2B | $4.1B | $4.2B | $4.5B | $4.7B | |
| Cash and Short Terms | $1B | $1.2B | $883.1M | $774.2M | $786.1M | |
| Total Debt | $35M | $7M | $180.6M | $393.4M | $70M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $241.9M | $277.8M | $46.9M | $54.5M | $131.2M | |
| Short Term Investments | $778.7M | $922.4M | $836.3M | $719.6M | $655M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1B | $1.2B | $883.1M | $833.5M | $849.6M | |
| Property Plant And Equipment | $85.3M | $75.3M | $72.1M | $73.7M | $74.3M | |
| Long-Term Investments | $778.7M | $922.4M | $836.3M | $719.6M | $665M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.2B | $4.1B | $4.2B | $4.5B | $4.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $17.9M | -- | -- | |
| Long-Term Debt | $35M | $7M | $180.6M | $393.4M | $70M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.7B | $3.7B | $3.9B | $4.2B | $4.3B | |
| Common Stock | $26.4M | $26.4M | $24M | $23M | $23.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $440.2M | $407.6M | $328.6M | $351.2M | $384.3M | |
| Total Liabilities and Equity | $4.2B | $4.1B | $4.2B | $4.5B | $4.7B | |
| Cash and Short Terms | $1B | $1.2B | $883.1M | $774.2M | $786.1M | |
| Total Debt | $35M | $7M | $180.6M | $393.4M | $70M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Depreciation & Amoritzation | $6.1M | $6.2M | $6.1M | $6.2M | $7.1M | |
| Stock-Based Compensation | $1M | $1M | $1.3M | $1.6M | $1.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.7M | $77.5M | $70.8M | $46.7M | $36.9M | |
| Capital Expenditures | $10.1M | $8.5M | $5.9M | $9.8M | $8.1M | |
| Cash Acquisitions | -- | -$73.9M | -- | -- | -- | |
| Cash From Investing | -$93.3M | -$106.4M | -$382.1M | -$307M | -$68.4M | |
| Dividends Paid (Ex Special Dividend) | -$3.7M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $25M | -- | $300.6M | $3.4B | $1.9B | |
| Long-Term Debt Repaid | -- | -- | -$127M | -$3.2B | -$2.2B | |
| Repurchase of Common Stock | -- | -$157K | -$42.9M | -$16.4M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $201.7M | $64.7M | $80.4M | $267.9M | $108.1M | |
| Beginning Cash (CF) | $125.8M | $241.9M | $277.8M | $46.9M | $54.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $116.1M | $35.9M | -$230.9M | $7.7M | $76.6M | |
| Ending Cash (CF) | $241.9M | $277.8M | $46.9M | $54.5M | $131.2M | |
| Levered Free Cash Flow | -$2.4M | $69.1M | $64.9M | $36.9M | $28.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.9M | $5.6M | $15.6M | -$1.9M | $8.3M | |
| Depreciation & Amoritzation | $1.6M | $1.6M | $1.6M | $1.6M | $1.8M | |
| Stock-Based Compensation | $211K | $268K | $304K | $390K | $428K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $18.9M | $17.5M | $23.1M | $7.9M | $11.5M | |
| Capital Expenditures | $1.7M | $2.2M | $1.7M | $1.8M | $3.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $1M | $25.6M | -$112M | -$51.5M | -$33.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $25M | -- | $277.6M | $3.1B | -- | |
| Long-Term Debt Repaid | -- | -- | -$127M | -$3.2B | -$1.9B | |
| Repurchase of Common Stock | -- | -$157K | -$2.8M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $70.8M | $8.8M | $70M | $42.8M | $48.4M | |
| Beginning Cash (CF) | $151.2M | $225.8M | $65.7M | $55.4M | $105M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $90.8M | $52M | -$18.8M | -$869K | $26.2M | |
| Ending Cash (CF) | $241.9M | $277.8M | $46.9M | $54.5M | $131.2M | |
| Levered Free Cash Flow | $17.2M | $15.3M | $21.4M | $6.1M | $8.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$45.9M | $31.6M | $50.1M | $23.4M | $24.5M | |
| Depreciation & Amoritzation | $6.1M | $6.2M | $6.1M | $6.2M | $7.1M | |
| Stock-Based Compensation | $1M | $1M | $1.3M | $1.6M | $1.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.7M | $77.5M | $70.8M | $46.7M | $36.9M | |
| Capital Expenditures | $10.1M | $8.5M | $5.9M | $9.8M | $8.1M | |
| Cash Acquisitions | -- | -$73.9M | -- | -- | -- | |
| Cash From Investing | -$93.3M | -$106.4M | -$382.1M | -$307M | -$68.4M | |
| Dividends Paid (Ex Special Dividend) | -$3.7M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $3.4B | -- | |
| Long-Term Debt Repaid | -- | -- | -$127M | -$3.2B | -$2.2B | |
| Repurchase of Common Stock | -- | -$157K | -$42.9M | -$16.4M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $201.7M | $64.7M | $80.4M | $267.9M | $108.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $116.1M | $35.9M | -$230.9M | $7.7M | $76.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$2.4M | $69.1M | $64.9M | $36.9M | $28.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $31.6M | $50.1M | $23.4M | $24.5M | -- | |
| Depreciation & Amoritzation | $6.2M | $6.1M | $6.2M | $7.1M | -- | |
| Stock-Based Compensation | $1M | $1.3M | $1.6M | $1.8M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $77.5M | $70.8M | $46.7M | $36.9M | -- | |
| Capital Expenditures | $8.5M | $5.9M | $9.8M | $8.1M | -- | |
| Cash Acquisitions | -$73.9M | -- | -- | -- | -- | |
| Cash From Investing | -$106.4M | -$382.1M | -$307M | -$68.4M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $300.6M | $3.4B | -- | -- | |
| Long-Term Debt Repaid | -- | -$127M | -$3.2B | -$2.2B | -- | |
| Repurchase of Common Stock | -$157K | -$42.9M | -$16.4M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $64.7M | $80.4M | $267.9M | $108.1M | -- | |
| Beginning Cash (CF) | $903.5M | $521.8M | $236.9M | $329.4M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $35.9M | -$230.9M | $7.7M | $76.6M | -- | |
| Ending Cash (CF) | $939.4M | $290.9M | $244.6M | $406M | -- | |
| Levered Free Cash Flow | $69.1M | $64.9M | $36.9M | $28.8M | -- | |
Get CARE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CARE
Sector
P/E ratio
15.40x
11.44x
PEG ratio
2.18x
0.38x
P/B ratio
0.98x
1.07x
Price / LTM sales
2.81x
2.47x
Growth Metrics
CARE
Sector
Revenue growth
12.36%
6.9%
Earnings growth
50%
7.04%
Revenue (5-year growth)
1.72%
5.27%
Earnings forecast
$0.30
$0.57
Profitability
CARE
Sector
Profitability FY 2024
--
$159.4M
Return on invested capital
4.16%
5.51%
Return on assets
0.54%
0.99%
Return on equity
6.64%
9.5%
Earnings Date
Last Earnings Date
Jan
23
Next Earnings Date
Apr
25
Estimated Next Earnings Date
Apr
24
Balance Sheet
CARE
Sector
Total cash
$786.1M
$471.6M
Short term investments
$655M
$263.5M
Total assets
$4.7B
$4.4B
Long term debt
$70M
$343.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 27
Ajinomoto [AJINY] is down 0% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 8.85% over the past day.
Sell
24
AIR alert for Mar 31
AAR [AIR] is down 1.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
